PIEX

Paris, France Founded: 1978 • Age: 48 yrs Acquired By LBO France
Diversified drugs are supplied by PIEX from Paris operations.
Annual revenue $1.3M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About PIEX

PIEX is a company based in Paris (France) founded in 1978 was acquired by LBO France in September 2017. PIEX operates in a competitive market with competitors including AmerisourceBergen, EUROTRANSPHARMA, TRIDEM Pharma, Nutravalia and e-THEMIS, among others.

  • Headquarter Paris, France
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Piex Group
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.34 M (USD)
    4
    as on Dec 31, 2022
  • Net Profit
    -$5.56 M (USD)
    -41
    as on Dec 31, 2022
  • EBITDA
    -$5.3 M (USD)
    -53
    as on Dec 31, 2022
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    LBO France

    (Sep 04, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of PIEX

Premium access

Detailed funding history for PIEX

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in PIEX

PIEX has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include LBO France.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investments are made in France and the US.
Locked Locked Locked
Premium access

Investor details for PIEX

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PIEX

Investments
Premium access

Investment portfolio details for PIEX

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - PIEX

Premium access

Detailed financials for PIEX

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Piex Comparisons

PIEX Primary company
Description
Diversified drugs are supplied by PIEX from Paris operations...
Location
Paris, France
Founded Year
1978
Annual Revenue
$1.34 M (USD)
Net Profit
-$5.56 M (USD)
EBITDA
-$5.3 M (USD)
Employees
Not available
Premium access

Peer comparison for PIEX

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PIEX

PIEX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, EUROTRANSPHARMA, TRIDEM Pharma, Nutravalia and e-THEMIS, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical distribution and supply chain services are provided globally.
Locked Locked Locked
Offers secure pharmaceutical distribution and last mile logistics services across Europe.
Locked Locked Locked
Pharmaceuticals are distributed by TRIDEM Pharma in France and Europe.
Locked Locked Locked
Manufacturer and distributor of food supplements, cosmetics, pharmaceutical, herbal teas, and derived products
Locked Locked Locked
Diversified drugs are distributed by e-THEMIS in pharmaceutical markets.
Premium access

Detailed competitors of PIEX

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Piex

Premium access

Complete news archive for PIEX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PIEX

PIEX was founded in 1978.

PIEX is headquartered in Paris, France.

Annual revenue of PIEX is $1.34M as on Dec 31, 2022.

PIEX was established in 1978 in Paris, France, as a supplier within the pharmaceutical sector. A variety of drugs is provided through diversified product lines, with operations centered in Europe. Services encompass distribution and supply chain management for healthcare needs. The company maintains its headquarters in France, focusing on regulatory-compliant pharmaceutical delivery across international markets.

PIEX's top competitors include AmerisourceBergen, TRIDEM Pharma and e-THEMIS.

PIEX has 1 investor. Key investors include LBO France.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available